INDUCTION OF ALLOANTIGEN-SPECIFIC HYPORESPONSIVENESS IN HUMAN LYMPHOCYTES-T BY BLOCKING INTERACTION OF CD28 WITH ITS NATURAL LIGAND B7/BB1

被引:509
作者
TAN, P
ANASETTI, C
HANSEN, JA
MELROSE, J
BRUNVAND, M
BRADSHAW, J
LEDBETTER, JA
LINSLEY, PS
机构
[1] FRED HUTCHINSON CANC RES CTR,DIV CLIN RES,HUMAN IMMUNOGENET PROGRAM,1124 COLUMBIA ST,SEATTLE,WA 98104
[2] UNIV WASHINGTON,DEPT MED,DIV ONCOL,SEATTLE,WA 98195
[3] BRISTOL MYERS SQUIBB CO,PHARMACEUT RES INST,SEATTLE,WA 98121
关键词
D O I
10.1084/jem.177.1.165
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The specificity of T lymphocyte activation is determined by engagement of the T cell receptor (TCR) by peptide/major histocompatibility complexes expressed on the antigen-presenting cell (APC). Lacking costimulation by accessory molecules on the APC, T cell proliferation does not occur and unresponsiveness to subsequent antigenic stimulus is induced. The B7/BB1 receptor on APCs binds CD28 and CTLA-4 on T cells, and provides a costimulus for T cell proliferation. Here, we show that prolonged, specific T cell hyporesponsiveness to antigenic restimulation is achieved by blocking the interaction between CD28 and B7/BB1 in human mixed leukocyte culture (MLC). Secondary T cell proliferative responses to specific alloantigen were inhibited by addition to the primary culture of monovalent Fab fragments of anti-CD28 monoclonal antibody (mAb) 9.3, which block interaction of CD28 with B7/BB1 without activating T cells. Hyporesponsiveness was also induced in MLC by CTLA4Ig, a chimeric immunoglobulin fusion protein incorporating the extracellular domain of CTLA-4 with high binding avidity for B7/BB1. Cells previously primed could also be made hyporesponsive, if exposed to alloantigen in the presence of CTLA4Ig. Maximal hyporesponsiveness was achieved in MLC after 2 d of incubation with CTLA4Ig, and was maintained for at least 27 d after removal of CTLA4Ig. Accumulation of interleukin 2 (IL-2) and interferon gamma but not IL-4 mRNA was blocked by CTLA4Ig in T cells stimulated by alloantigen. Antigen-specific responses could be restored by addition of exogenous IL-2 at the time of the secondary stimulation. Addition to primary cultures of the intact bivalent anti-CD28 mAb 9.3, of B7/BB1 + transfected CHO cells or exogenous IL-2, abrogated induction of hyporesponsiveness by CTLA4Ig. These data indicate that interaction of CD28 with B7/BB1 during TCR engagement with antigen is required to maintain T cell competence and that blocking such interaction can result in a state of T cell hyporesponsiveness.
引用
收藏
页码:165 / 173
页数:9
相关论文
共 44 条
  • [1] CD28 INTERACTION WITH B7-COSTIMULATES PRIMARY ALLOGENEIC PROLIFERATIVE RESPONSES AND CYTOTOXICITY MEDIATED BY SMALL, RESTING LYMPHOCYTES-T
    AZUMA, M
    CAYABYAB, M
    BUCK, D
    PHILLIPS, JH
    LANIER, LL
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (02) : 353 - 360
  • [2] BIERER BE, 1989, ANNU REV IMMUNOL, V7, P589
  • [3] CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
  • [4] DIRECT HELPER T-CELL-INDUCED B-CELL DIFFERENTIATION INVOLVES INTERACTION BETWEEN T-CELL ANTIGEN-CD28 AND B-CELL ACTIVATION ANTIGEN-B7
    DAMLE, NK
    LINSLEY, PS
    LEDBETTER, JA
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1991, 21 (05) : 1277 - 1282
  • [5] HUMAN IG SUPERFAMILY CTLA-4 GENE - CHROMOSOMAL LOCALIZATION AND IDENTITY OF PROTEIN-SEQUENCE BETWEEN MURINE AND HUMAN CTLA-4 CYTOPLASMIC DOMAINS
    DARIAVACH, P
    MATTEI, MG
    GOLSTEIN, P
    LEFRANC, MP
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1988, 18 (12) : 1901 - 1905
  • [6] DESILVA DS, 1991, J IMMUNOL, V147, P2461
  • [7] REGULATION OF INTERLEUKIN-2 GENE ENHANCER ACTIVITY BY THE T-CELL ACCESSORY MOLECULE CD28
    FRASER, JD
    IRVING, BA
    CRABTREE, GR
    WEISS, A
    [J]. SCIENCE, 1991, 251 (4991) : 313 - 316
  • [8] FREEMAN GJ, 1989, J IMMUNOL, V143, P2714
  • [9] STRUCTURE, EXPRESSION, AND T-CELL COSTIMULATORY ACTIVITY OF THE MURINE HOMOLOG OF THE HUMAN LYMPHOCYTE-B ACTIVATION ANTIGEN-B7
    FREEMAN, GJ
    GRAY, GS
    GIMMI, CD
    LOMBARD, DB
    ZHOU, LJ
    WHITE, M
    FINGEROTH, JD
    GRIBBEN, JG
    NADLER, LM
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (03) : 625 - 631
  • [10] FREEMAN GJ, 1990, BLOOD, V76, pA206